Analysis of outcome in patients reirradiated for brain metastases

Wong, William W.; Schild, Steven E.; Sawyer, Timothy; Shaw, Edward G.

doi:10.1016/0360-3016(95)02156-6

Cited by 135 publications

(79 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[24][25][26] diosurgery have reported survivals similar to those for surgically treated patients. In the series reported by Patients without active extracranial tumors surFlickinger et al, median survival after radiosurgery for vived significantly longer than those with active extraa solitary metastasis was 11 months, 5 and Auchter et cranial tumors as has been reported by others.…”

Section: -mentioning

confidence: 99%

Stereotactic radiosurgery for the treatment of brain metastases

Breneman

Warnick

Albright

et al. 1997

Cancer

154

View full text Add to dashboard Cite

Section: -mentioning

confidence: 99%

Stereotactic radiosurgery for the treatment of brain metastases

Breneman

Warnick

Albright

et al. 1997

Cancer

154

View full text Add to dashboard Cite

“…The application of this novel technique for the treatment of the whole brain is exciting and may carry promise for further evaluation. Unlike upfront management of brain metastases patients, the literature is relatively limited for guiding treatment of patients with intracranial relapse after WBRT [6][7][8][9][10][11][12][13], despite its occurrence in 47-86% of patients [5]. Furthermore, recommendations are often conflicting, and the existing series span decades over which patient survival and RT delivery techniques have changed significantly [6][7][8][9][10][11][12][13].…”

Section: Discussionmentioning

confidence: 99%

“…Potential interventions after WBRT include surgical resection, chemotherapy, SRS, or repeat WBRT. The radiation dose given at the time of repeat WBRT generally is reduced secondary to toxicity concerns and ranges from 20 to 30 Gy [6][7][8][9][10][11][12][13]. This only provides limited biologic effect on gross disease, yet still carries a substantial risk for neurocognitive delay to the patient.…”

Section: Introductionmentioning

confidence: 99%

Repeat Whole Brain Radiation Therapy with a Simultaneous Infield Boost: A Novel Technique for Reirradiation

Hall

Prabhu

Crocker

et al. 2014

Journal of Radiotherapy

View full text Add to dashboard Cite

The treatment of patients who experience intracranial progression after whole brain radiation therapy (WBRT) is a clinical challenge. Novel radiation therapy delivery technologies are being applied with the objective of improving tumor and symptom control in these patients. The purpose of this study is to describe the clinical outcomes of the application of a novel technology to deliver repeat WBRT with volume modulated arc therapy (VMAT) and a simultaneous infield boost (WB-SIB) to gross disease. A total of 16 patients were initially treated with WBRT between 2000 and 2008 and then experienced intracranial progression, were treated using repeat WB-SIB, and were analyzed. The median dose for the first course of WBRT was 35 Gy (range: 30-50.4 Gy). Median time between the initial course of WBRT and repeat WB-SIB was 11.3 months. The median dose at reirradiation was 20 Gy to the whole brain with a median boost dose of 30 Gy to gross disease. A total of 2 patients demonstrated radiographic disease progression after treatment. The median overall survival (OS) time from initial diagnosis of brain metastases was 18.9 months (range: 7.1-66.6 (95% CI: 0.8-36.9)). The median OS time after initiation of reirradiation for all patients was 2.7 months (range: 0.46-14.46 (95% CI: 1.3-8.7)). Only 3 patients experienced CTCAE grade 3 fatigue. No other patients experienced any ≥ CTCAE grade 3 toxicity. This analysis reports the result of a novel RT delivery technique for the treatment of patients with recurrent brain metastases. Side effects were manageable and comparable to other conventional repeat WBRT series. Repeat WB-SIB using the VMAT RT delivery technology is feasible and appears to have acceptable short-term acute toxicity. These results may provide a foundation for further exploration of the WB-SIB technique for repeat WBRT in future prospective clinical trials.

show abstract

“…The dose of the initial course of cranial irradiation varied from 20 to 50.4 Gy, and reirradiation schedules range from 25 to 30 Gy in 10-15 fractions or 20 Gy in 5-10 fractions. In general, doses greater than 20 Gy were associated with better outcome [25].…”

Section: Whole Brain Reirradiationmentioning

confidence: 91%

Conventional radiation therapy for brain metastases

2012

View full text Add to dashboard Cite

Conventional radiotherapy in the form of whole brain radiation treatment has been a longstanding treatment for brain metastases, and it continues to provide effective palliation as monotherapy and in combination with local and systemic treatments. Advances in systemic therapy have improved survival with metastatic disease, and in those patients with better prognostic factors, more aggressive local therapeutic approaches for brain metastases appear to benefit their survival and intracranial tumor control. Increased treatment intensity and longer survival following treatment of brain metastases have raised concerns about persistent treatmentrelated neurocognitive toxicities and the resulting impact on quality of life. Technological advances in conventional radiotherapy planning and delivery have led to novel approaches that may increase intracranial tumor control while minimizing the treatment-related toxicities of therapy. These innovative approaches include intensitymodulated radiotherapy, new image-guidance techniques, and volumetric modulated arc therapy, which allow for the delivery of whole brain radiotherapy with integrated boost treatment to the visible disease while sparing the hippocampal regions or delivery of hypofractionated radiotherapy to larger metastatic targets that may not be amenable to radiosurgery boost or salvage treatment.

show abstract

Analysis of outcome in patients reirradiated for brain metastases

Cited by 135 publications

References 16 publications

Stereotactic radiosurgery for the treatment of brain metastases

Stereotactic radiosurgery for the treatment of brain metastases

Repeat Whole Brain Radiation Therapy with a Simultaneous Infield Boost: A Novel Technique for Reirradiation

Conventional radiation therapy for brain metastases

Contact Info

Product

Resources

About